Regorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-07 收录
官方服务：
资源简介：
The purpose of this study is to assess the efficacy and safety of single-agent regorafenib in the first line treatment of frail and/or unfit for polychemotherapy patients with metastatic colorectal cancer (mCRC)
创建时间：
2013-06-15
